Biotech Values

[Mufaso]

Viking Therapeutics Signs Broad Manufacturing Agreement With CordenPharma to Support Commercialization of VK2735.

https://ir.vikingtherapeutics.com/2025-03-11-Viking-Therapeutics-Signs-Broad-Manufacturing-Agreement-With-CordenPharma-to-Support-Commercialization-of-VK2735

I'm pretty happy with this deal with Corden. Its a really good one for VKTX IMO. Yes and up front payment of $150mill but but they get it back as a credit on purchases and now have a huge supply capability. I didn't think they (Corden) were in the running simply because LLY is using them to make Trizepatide. Maybe with all of LLY investment in new factories, they had no long term commitments from LLY and were desperate to backfill orders and maintain capacity?

All in all, very encouraging VKTX again IMO.

As a side note, I have no idea where the stock trades today. Some may view this as it diminishes buyout chances. I would disagree with that as I don't think any big pharma plans to make peptides on their own going forward with the exceptions being LLY and NVO. In any event I don't care, If no BP wants to provide a fair offer for VKTX, then I'm happy to see them go it alone as this deal proves they can.